In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia
| Autor: | Enza Di Leo, Davide Bocchi, Patrizia Tarugi, Stefano Bertolini, Maria Luisa Simone, Claudio Rabacchi, Antonello Pietrangelo, Livia Pisciotta, Sebastiano Calandra, Sergio D'Addato |
|---|---|
| Přispěvatelé: | Rabacchi C., Simone M.L., Pisciotta L., Di Leo E., Bocchi D., Pietrangelo A., D'Addato S., Bertolini S., Calandra S., Tarugi P. |
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male Nonsynonymous substitution Truncated apoB Apolipoprotein B Splicing variants RNA Splicing Endocrinology Diabetes and Metabolism In silico Intron 030204 cardiovascular system & hematology Chlorocebus aethiop Splicing variant Hypobetalipoproteinemias 03 medical and health sciences Exon 0302 clinical medicine COS Cell Chlorocebus aethiops Internal Medicine Animals Humans Medicine 030212 general & internal medicine Familial hypobetalipoproteinemia APOB gene Aged Genetics Nutrition and Dietetics biology Animal business.industry Middle Aged Introns Exon skipping Truncated apoBs COS Cells Apolipoprotein B-100 RNA splicing Codon Terminator biology.protein Female Cardiology and Cardiovascular Medicine business Hypobetalipoproteinemia Human Minigene |
| Popis: | Background: Familial hypobetalipoproteinemia type 1 (FHBL-1) is a codominant disorder characterized by greatly reduced plasma levels of total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B. Rare exonic pathogenic variants of APOB gene (nonsense variants, minute deletions/insertions and nonsynonymous variants) have been frequently reported in subjects with FHBL-1. Also, rare intronic variants of APOB located at intron/exon junctions and assumed to affect splicing have been reported. However, the pathogenicity of most of these intronic variants remains to be established. Objective: The objective of this study was the in vitro functional characterization of six splicing variants of APOB gene identified in seven putative FHBL-1 heterozygotes. Methods: ApoB minigenes harboring each variant were expressed in COS-1 cells and their transcripts were sequenced. Results: Four novel variants (c.237+1G>A, c.818+5G>A, c.3000-1G>T, and c.3842+1G>A), predicted in silico to obliterate splice site activity, were found to generate abnormal transcripts. The abnormal transcripts were generated by the activation of cryptic splice sites or exon skipping. All these transcripts harbored a premature termination codon and were predicted to encode truncated apoBs devoid of function. The predicted translation products were: i) p.(Lys41Serfs*2) and p.(Val80Ilefs*10) for c.237+1G>A; ii) p.(Asn274*) for c.818+5G>A; iii) p.(Leu1001Alafs*10) for c.3000-1G>T, and iv) p.(Ser1281Argfs*2) for c.3842+1G>A. Two previously annotated rare variants (c.905-15C>G and c.1618-4G>A) with uncertain effect in silico were found to generate only wild-type transcripts. Conclusions: These in vitro minigene expression studies support the assignment of pathogenicity to four novel splice site variants of APOB gene found in FHBL-1. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|